Proton pump inhibitor concomitant use to prevent oxaliplatin‐induced peripheral neuropathy: Clinical retrospective cohort study
These results suggest that concomitant PPI use may reduce oxaliplatin discontinuation due to OIPN in patients receiving oxaliplatin.
Authors
- Takao Shimazoe (ORCID: https://orcid.org/0000-0003-3584-1603)
- Keisuke Mine (ORCID: https://orcid.org/0009-0009-8409-7260)
- Takehiro Kawashiri (ORCID: https://orcid.org/0000-0002-7708-2855)
- Satoru Koyanagi (ORCID: https://orcid.org/0000-0003-4849-2377)
- Daisuke Kobayashi (ORCID: https://orcid.org/0000-0002-7312-9919)
- Yusuke Mori (ORCID: https://orcid.org/0000-0003-2142-4665)
- Shigehiro Ohdo (ORCID: https://orcid.org/0000-0003-4795-9764)
- Takaaki Yamada (ORCID: https://orcid.org/0000-0001-7009-1727)
- Shunsuke Fujita (ORCID: https://orcid.org/0009-0006-9526-5934)
- Ichiro Ieiri (ORCID: https://orcid.org/0000-0002-3543-2562)
- Nobuaki Egashira (ORCID: https://orcid.org/0000-0002-3673-6824)
- Mayako Uchida (ORCID: https://orcid.org/0000-0003-0507-7309)
- Haruna Ishida
- Hibiki Kudamatsu
- Kohei Mori
Institutions
- Kyushu University (JP)
- Wakayama Medical University (JP)
- Fukuoka International University (JP)
- Kyushu University Hospital (JP)
- International University of Health and Welfare (JP)
Publication Details
- Journal
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
- Published
- 2025-05-10
- DOI
- https://doi.org/10.1002/phar.70028
- Citations
- 6
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 6.27
Funders
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency